SIMULATIONS PLUS INC (SLP) Stock Price & Overview

NASDAQ:SLPUS8292141053

Current stock price

13 USD
+0.35 (+2.77%)
At close:
13.49 USD
+0.49 (+3.77%)
After Hours:

The current stock price of SLP is 13 USD. Today SLP is up by 2.77%. In the past month the price increased by 6.04%. In the past year, price decreased by -60.18%.

SLP Key Statistics

52-Week Range11.09 - 36.45
Current SLP stock price positioned within its 52-week range.
1-Month Range11.09 - 13.3
Current SLP stock price positioned within its 1-month range.
Market Cap
261.95M
P/E
21.67
Fwd P/E
23.29
EPS (TTM)
0.60
Dividend Yield
0.61%

SLP Stock Performance

Today
+2.77%
1 Week
+9.98%
1 Month
+6.04%
3 Months
-33.67%
Longer-term
6 Months -11.92%
1 Year -60.18%
2 Years -71.33%
3 Years -68.86%
5 Years -79.41%
10 Years +61.29%

SLP Stock Chart

SIMULATIONS PLUS INC / SLP Daily stock chart

SLP Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to SLP. When comparing the yearly performance of all stocks, SLP is a bad performer in the overall market: 94.18% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SLP Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to SLP. SLP has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SLP Earnings

On January 8, 2026 SLP reported an EPS of 0.03 and a revenue of 18.42M. The company missed EPS expectations (-77.15% surprise) and beat revenue expectations (0.77% surprise).

Next Earnings DateApr 9, 2026
Last Earnings DateJan 8, 2026
PeriodQ1 / 2026
EPS Reported$0.03
Revenue Reported18.421M
EPS Surprise -77.15%
Revenue Surprise 0.77%

SLP Forecast & Estimates

11 analysts have analysed SLP and the average price target is 25.25 USD. This implies a price increase of 94.19% is expected in the next year compared to the current price of 13.

For the next year, analysts expect an EPS growth of -5.97% and a revenue growth 2.12% for SLP


Analysts
Analysts76.36
Price Target25.25 (94.23%)
EPS Next Y-5.97%
Revenue Next Year2.12%

SLP Groups

Sector & Classification

SLP Financial Highlights

Over the last trailing twelve months SLP reported a non-GAAP Earnings per Share(EPS) of 0.6. The EPS increased by 50% compared to the year before.


Income Statements
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Industry RankSector Rank
PM (TTM) N/A
ROA -46.61%
ROE -50.54%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%200%
Sales Q2Q%-2.66%
EPS 1Y (TTM)50%
Revenue 1Y (TTM)5.69%

SLP Ownership

Ownership
Inst Owners86.75%
Shares20.15M
Float16.64M
Ins Owners17.33%
Short Float %7.54%
Short Ratio4.18

About SLP

Company Profile

SLP logo image Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Company Info

IPO: 1997-06-18

SIMULATIONS PLUS INC

800 Park Offices Drive, Suite 401

RESEARCH TRIANGLE PARK NORTH CAROLINA 93534 US

CEO: Shawn O'Connor

Employees: 212

SLP Company Website

SLP Investor Relations

Phone: 16617237723

SIMULATIONS PLUS INC / SLP FAQ

What does SIMULATIONS PLUS INC do?

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 212 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.


Can you provide the latest stock price for SIMULATIONS PLUS INC?

The current stock price of SLP is 13 USD. The price increased by 2.77% in the last trading session.


What is the dividend status of SIMULATIONS PLUS INC?

SIMULATIONS PLUS INC (SLP) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.


What is the ChartMill rating of SIMULATIONS PLUS INC stock?

SLP has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the upcoming dividend date for SIMULATIONS PLUS INC?

The next ex-dividend date for SIMULATIONS PLUS INC (SLP) is July 29, 2024.


Can you provide the ownership details for SLP stock?

You can find the ownership structure of SIMULATIONS PLUS INC (SLP) on the Ownership tab.


What is the Short Interest ratio of SIMULATIONS PLUS INC (SLP) stock?

The outstanding short interest for SIMULATIONS PLUS INC (SLP) is 7.54% of its float.